ENTITY

Taigen Biopharmaceuticals (4157 TT)

1
Analysis
Health CareTaiwan
TaiGen Biopharmaceuticals Holdings Limited is a research-based pharmaceutical company engaging in the development of novel therapeutics for infectious diseases, cancer research and diabetes-related complications.
more
Refresh
Publication Icon
No publications yet
There aren’t any broker reports right now
Back to "All"
x